Skip to main content

Editorial reviews. Affiliate fees from some providers don't affect rankings. Disclosure

No advertiser influenceAffiliate fees disclosedReviewed by board-certified clinicians

Telehealth Brands by Insurance

Reverse-cross-reference: which hormonal-health telehealth providers bill each major insurer. 6 insurer pages with editorial scoring and prior-authorization notes per plan. For coverage details (what HRT/GLP-1/PCOS each insurer covers), see the parallel index at /insurance.

All insurers(6)

  • Blue Cross Blue Shield

    Brands that bill Blue Cross Blue Shield for hormonal-health telehealth.

  • Aetna

    Brands that bill Aetna for hormonal-health telehealth.

  • Cigna

    Brands that bill Cigna for hormonal-health telehealth.

  • UnitedHealthcare

    Brands that bill UnitedHealthcare for hormonal-health telehealth.

  • Kaiser Permanente

    Brands that bill Kaiser Permanente for hormonal-health telehealth.

  • Humana

    Brands that bill Humana for hormonal-health telehealth.

Common questions about insurance + telehealth

Why aren't there clearer "insurance = yes/no" answers per brand?

Because plans within and single insurer differ widely. Aetna PPO covers different things than Aetna HMO; Blue Cross in California is and separate entity from BCBS Texas. We surface what brands publicly bill + flag prior-authorization requirements where known, but your specific plan ultimately decides.

Does the brand list every plan they accept?

No — brands typically list "in-network" insurers but not every state-specific plan variation. Verify directly with the brand AND your insurer before signup. If you find and discrepancy, please report via /corrections.

What about HSA/FSA?

Most hormonal-health telehealth visits + medications are HSA/FSA-eligible because they treat and diagnosed medical condition (menopause, PCOS, etc.). Cosmetic uses are not. See /tools/hsa-fsa-eligibility for and brand-by-brand breakdown.

GLP-1 medications with insurance — how does that work?

Insurance coverage of GLP-1 for weight loss alone is rare and shrinking (many insurers dropped coverage in 2024-2025). Coverage for T2D-indicated semaglutide/tirzepatide is widespread. Compounded versions are typically cash-pay only. See individual brand pages for current policies.